Roche CLEMATIS trial discontinued

Statement on CLEMATIS trial June 28, 2016 The CLEMATIS trial was a Phase II study investigating the efficacy and safety of basmisanil (RG1662) in adults and adolescents with Down syndrome. … Read more

Poseidon Project

POSEIDON is a 3 year project which has been sponsored by the European Commission. It aims to create information technology which will support people with Down’s syndrome achieve a greater level of independence in … Read more

UN recognise World Down Syndrome Day

EDSA welcomes the decision by the United Nations (UN) to officially recognise and endorse World Down Syndrome Day, 21st March. Recognition will help to safeguard the rights of individuals with Down … Read more